• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素的二聚体衍生物在溶液中和表面与L-赖氨酸-D-丙氨酸-D-乳酸的结合。

Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.

作者信息

Rao J, Yan L, Lahiri J, Whitesides G M, Weis R M, Warren H S

机构信息

Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, MA 02138, USA.

出版信息

Chem Biol. 1999 Jun;6(6):353-9. doi: 10.1016/S1074-5521(99)80047-7.

DOI:10.1016/S1074-5521(99)80047-7
PMID:10375541
Abstract

BACKGROUND

The emergence of bacteria that are resistant to vancomycin (V), a glycopeptide antibiotic, results from the replacement of the carboxy-terminal D-Ala-D-Ala of bacterial cell wall precursors by D-Ala-D-lactate. Recently, it has been demonstrated that covalent dimeric variants of V are active against vancomycin-resistant enterococci (VRE). To study the contribution of divalency to the activities of these variants, we modeled the interactions of V and a dimeric V with L-Lys-D-Ala-D-lactate, an analog of the cell-wall precursors of the vancomycin-resistant bacteria.

RESULTS

A dimeric derivative of V (V-Rd-V) was found to be much more effective than V in inhibiting the growth of VRE. The interactions of V and V-Rd-V with a monomeric lactate ligand - diacetyl-L-Lys-D-Ala-D-lactate (Ac2KDADLac) - and a dimeric derivative of L-Lys-D-Ala-D-lactate (Lac-R'd-Lac) in solution have been examined using isothermal titration calorimetry and UV spectroscopy titrations; the results reveal that V-Rd-V binds Lac-R'd-Lac approximately 40 times more tightly than V binds Ac2KDADLac. Binding of V and of V-Rd-V to Nalpha-Ac-L-Lys-D-Ala-D-lactate presented on the surface of mixed self-assembled monolayers (SAMs) of alkanethiolates on gold indicates that the apparent off-rate for dissociation of V-Rd-V from the surface is much slower than that of V from the same surface.

CONCLUSIONS

The results are compatible with the hypothesis that divalency is responsible for tight binding, which correlates with small values of minimum inhibitory concentrations of V and V-Rd-V.

摘要

背景

万古霉素(V)是一种糖肽类抗生素,对其耐药的细菌的出现是由于细菌细胞壁前体的羧基末端D - 丙氨酰 - D - 丙氨酸被D - 丙氨酰 - D - 乳酸取代。最近,已证明V的共价二聚体变体对万古霉素耐药肠球菌(VRE)具有活性。为了研究二价性对这些变体活性的贡献,我们模拟了V和二聚体V与L - 赖氨酸 - D - 丙氨酰 - D - 乳酸(万古霉素耐药细菌细胞壁前体的类似物)之间的相互作用。

结果

发现V的二聚体衍生物(V - Rd - V)在抑制VRE生长方面比V有效得多。使用等温滴定量热法和紫外光谱滴定法研究了V和V - Rd - V与单体乳酸配体 - 二乙酰 - L - 赖氨酸 - D - 丙氨酰 - D - 乳酸(Ac2KDADLac)以及L - 赖氨酸 - D - 丙氨酰 - D - 乳酸的二聚体衍生物(Lac - R'd - Lac)在溶液中的相互作用;结果表明,V - Rd - V与Lac - R'd - Lac的结合比V与Ac2KDADLac的结合紧密约40倍。V和V - Rd - V与金表面烷硫醇混合自组装单分子层(SAMs)表面呈现的Nα - 乙酰 - L - 赖氨酸 - D - 丙氨酰 - D - 乳酸的结合表明,V - Rd - V从表面解离的表观解离速率比V从同一表面解离的速率慢得多。

结论

结果与二价性导致紧密结合的假设一致,这与V和V - Rd - V的最小抑菌浓度值较小相关。

相似文献

1
Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface.万古霉素的二聚体衍生物在溶液中和表面与L-赖氨酸-D-丙氨酸-D-乳酸的结合。
Chem Biol. 1999 Jun;6(6):353-9. doi: 10.1016/S1074-5521(99)80047-7.
2
First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.万古霉素和替考拉宁与细菌细胞壁末端结合的第一性原理研究。
J Am Chem Soc. 2004 Jul 14;126(27):8384-5. doi: 10.1021/ja048645c.
3
Crystal structures of the complexes between vancomycin and cell-wall precursor analogs.万古霉素与细胞壁前体类似物复合物的晶体结构。
J Mol Biol. 2009 Feb 6;385(5):1422-32. doi: 10.1016/j.jmb.2008.10.026. Epub 2008 Oct 19.
4
Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions.将万古霉素对D-丙氨酰-D-乳酸结合亲和力的损失划分为氢键损失和孤对电子排斥贡献。
J Am Chem Soc. 2003 Aug 6;125(31):9314-5. doi: 10.1021/ja035901x.
5
Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues.糖肽类抗生素苷元与细胞壁类似物的结构及结合的量子模拟
J Phys Chem B. 2005 Nov 3;109(43):20588-96. doi: 10.1021/jp0548117.
6
D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci.对于万古霉素二聚体针对耐万古霉素肠球菌的高活性而言,D-丙氨酸-D-乳酸结合并非必需。
J Am Chem Soc. 2003 Jul 23;125(29):8740-1. doi: 10.1021/ja0359761.
7
Molecular interactions between glycopeptide vancomycin and bacterial cell wall peptide analogues.糖肽万古霉素与细菌细胞壁肽类似物之间的分子相互作用。
Chemistry. 2011 Dec 9;17(50):14170-7. doi: 10.1002/chem.201102195. Epub 2011 Nov 14.
8
Experimental and theoretical studies of the structures and interactions of vancomycin antibiotics with cell wall analogues.万古霉素抗生素与细胞壁类似物的结构及相互作用的实验与理论研究。
J Am Chem Soc. 2008 Oct 1;130(39):13013-22. doi: 10.1021/ja802643g. Epub 2008 Sep 6.
9
Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, beta-lactam antibiotics and antibiotic resistance mechanisms.细菌细胞壁肽的构象分析表明特定构象如何影响青霉素结合蛋白、β-内酰胺抗生素及抗生素耐药机制的进化。
J Mol Recognit. 2002 May-Jun;15(3):113-25. doi: 10.1002/jmr.566.
10
Binding of vancomycin group antibiotics to D-alanine and D-lactate presenting self-assembled monolayers.万古霉素类抗生素与呈现D-丙氨酸和D-乳酸的自组装单分子层的结合。
Bioorg Med Chem. 2000 Nov;8(11):2609-16. doi: 10.1016/s0968-0896(00)00184-x.

引用本文的文献

1
Protection of gut microbiome from antibiotics: development of a vancomycin-specific adsorbent with high adsorption capacity.保护肠道微生物群免受抗生素影响:开发具有高吸附能力的万古霉素特异性吸附剂。
Biosci Microbiota Food Health. 2020;39(3):128-136. doi: 10.12938/bmfh.2020-002. Epub 2020 Feb 29.
2
Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance.已批准的糖肽类抗菌药物:作用机制与耐药性
Cold Spring Harb Perspect Med. 2016 Dec 1;6(12):a026989. doi: 10.1101/cshperspect.a026989.
3
The effect of environment on the recognition and binding of vancomycin to native and resistant forms of lipid II.
环境对万古霉素识别和结合天然和耐药形式的脂质 II 的影响。
Biophys J. 2011 Dec 7;101(11):2684-92. doi: 10.1016/j.bpj.2011.10.047.
4
Host-guest chemistry of the peptidoglycan.肽聚糖的主客体化学
J Med Chem. 2010 Jul 8;53(13):4813-29. doi: 10.1021/jm100086u.
5
Polymerizable vancomycin derivatives for bactericidal biomaterial surface modification: structure-function evaluation.用于杀菌生物材料表面改性的可聚合万古霉素衍生物:结构-功能评估
Biomacromolecules. 2009 Aug 10;10(8):2221-34. doi: 10.1021/bm900410a.
6
Oritavancin binds to isolated protoplast membranes but not intact protoplasts of Staphylococcus aureus.奥利万星可与分离的金黄色葡萄球菌原生质体膜结合,但不能与完整的原生质体结合。
J Mol Biol. 2009 Aug 14;391(2):414-25. doi: 10.1016/j.jmb.2009.06.033. Epub 2009 Jun 16.
7
Using self-assembled monolayers to model the extracellular matrix.利用自组装单分子层模拟细胞外基质。
Acta Biomater. 2009 Mar;5(3):832-41. doi: 10.1016/j.actbio.2009.01.016. Epub 2009 Jan 27.
8
Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate.对万古霉素耐药菌株具有活性的万古霉素类似物可抑制细菌转糖基酶而不结合底物。
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5658-63. doi: 10.1073/pnas.0931492100. Epub 2003 Apr 24.